Literature DB >> 26464039

The nature of anhedonia and avolition in patients with first-episode schizophrenia.

S S Y Lui1, A C Y Liu2, W W H Chui2, Z Li1, F Geng1, Y Wang1, E A Heerey3, E F C Cheung2, R C K Chan1.   

Abstract

BACKGROUND: Patients with schizophrenia have intact ability to experience emotion, but empirical evidence suggests that they fail to translate emotional salience into effortful behaviour. Previous research in patients with chronic schizophrenia suggests that working memory is important in integrating emotion and behaviour. This study aimed to examine avolition and anhedonia in patients with first-episode schizophrenia and clarify the role of working memory in emotion-behaviour coupling.
METHOD: We recruited 72 participants with first-episode schizophrenia and 61 healthy controls, and used a validated emotion-inducing behavioural paradigm to measure participants' affective experiences and how experienced emotion coupled with behaviour. Participants were given the opportunity to expend effort to increase or decrease their exposure to emotion-inducing photographs. Participants with schizophrenia having poor working memory were compared with those with intact working memory in their liking and emotion-behaviour coupling.
RESULTS: Patients with first-episode schizophrenia experienced intact 'in-the-moment' emotion, but their emotion was less predictive of the effort expended, compared with controls. The emotion-behaviour coupling was significantly weaker in patients with schizophrenia with poor working memory than in those with intact working memory. However, compared with controls, patients with intact working also showed substantial emotion-behaviour decoupling.
CONCLUSIONS: Our findings provide strong evidence for emotion-behaviour decoupling in first-episode schizophrenia. Although working memory deficits contribute to defective translation of liking into effortful behaviour, schizophrenia alone affects emotion-behaviour coupling.

Entities:  

Keywords:  Anhedonia; avolition; first-episode schizophrenia; schizophrenia; working memory

Mesh:

Year:  2015        PMID: 26464039     DOI: 10.1017/S0033291715001968

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  6 in total

1.  Social motivation in people with recent-onset schizophrenia spectrum disorders.

Authors:  Timothy R Campellone; Brandy Truong; David Gard; Danielle A Schlosser
Journal:  J Psychiatr Res       Date:  2018-01-12       Impact factor: 4.791

2.  Perspectives on Machine Learning for Classification of Schizotypy Using fMRI Data.

Authors:  Kristoffer H Madsen; Laerke G Krohne; Xin-Lu Cai; Yi Wang; Raymond C K Chan
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

3.  Social motivation and behavior in first-episode psychosis: Unique contributions to social quality of life and social functioning.

Authors:  Aubrey M Moe; David M Weiss; Jacob G Pine; Heather M Wastler; Nicholas J K Breitborde
Journal:  J Psychiatr Res       Date:  2021-11-03       Impact factor: 4.791

Review 4.  Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits.

Authors:  Sugai Liang; Yue Wu; Li Hanxiaoran; Andrew J Greenshaw; Tao Li
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-07       Impact factor: 2.989

5.  Investigating the association of ventral and dorsal striatal dysfunction during reward anticipation with negative symptoms in patients with schizophrenia and healthy individuals.

Authors:  Marta Stepien; Andrei Manoliu; Roman Kubli; Karoline Schneider; Philippe N Tobler; Erich Seifritz; Marcus Herdener; Stefan Kaiser; Matthias Kirschner
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

Review 6.  The role of hedonics in the Human Affectome.

Authors:  Susanne Becker; Anne-Kathrin Bräscher; Scott Bannister; Moustafa Bensafi; Destany Calma-Birling; Raymond C K Chan; Tuomas Eerola; Dan-Mikael Ellingsen; Camille Ferdenzi; Jamie L Hanson; Mateus Joffily; Navdeep K Lidhar; Leroy J Lowe; Loren J Martin; Erica D Musser; Michael Noll-Hussong; Thomas M Olino; Rosario Pintos Lobo; Yi Wang
Journal:  Neurosci Biobehav Rev       Date:  2019-05-06       Impact factor: 8.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.